References
- Fylaktakidou K, Hadjipavlou-Litina D, Litinas K, Nicolaides D. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activity. Curr Pharm Des 2004; 30: 3813–3833
- Egan D, Kennedy RO, Moran E, Cox D, Prosser E, Thornes D. The pharmacology, metabolism, analysis and applications of coumarin and coumarin related compounds. Drug Metab Rev 1990; 22: 503–529
- Murray RDH, Mendez I, Brawn SA. The natural coumarins. Wiley, New York 1982
- Paya M, Halliwell B, Hoult JRS. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol 1992; 44: 205–214
- Kontogiorgis C, Hadjipavlou-Litina D. Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidants agents. J Enzyme Inhib Med Chem 2003; 18: 63–69
- Kontogiorgis C, Hadjipavlou-Litina D. Synthesis and anti-inflammatory activity of coumarin derivatives. J Med Chem 2005; 48: 6400–6408
- Kimura Y, Okuda H, Arichi S, Baba K, Kozawa M. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetranoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim Biophys Acta 1985; 834: 224–229
- Yoshimoto T, Furukawa M, Yamamoto S, Horie T, Kohno W. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 1983; 116: 612–618
- Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr Med Chem 2005; 12(8)887–916
- Tegtmeier M, Legrum W. 7-amino-coumarins as substrates of cytochrome P450-isozymes. Arch Pharm 1998; 331: 143–148
- Katerinopoulos HE. The coumarin moiety as chromophore of fluorescent ion indicators in biological systems. Curr Pharm Des 2004; 10: 3835–3852
- Dakanali M, Roussakis E, Kay AR, Katerinopoulos HE. Synthesis and photophysical properties of a fluorescent TREN-type ligand incorporating the coumarin chromophore and its zinc complex. Tetrahedron Lett 2005; 46: 4193–4196
- , Katerinopoulos HE, Foukaraki E, Liepouri F, Akoumianaki A, Deligeorgiev TG. Synthesis and fluorescent spectra of potential fluorescent ion indicators. 220th Amer Chem Soc Meeting, Washington DC, August 2000, MEDI 273.
- Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450
- Ellis GA, Blake DR. Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping. Ann Rheum Dis 1993; 241–243
- Day RO, Graham GG, Williams KM, Brooks PM. Variability in response to NSAIDs. Fact or fiction?. Drugs 1988; 643–651
- Brooks PM, Day RO. Non steroidal anti-inflammatory drugs—differences and similarities. N Eng J Med 1988; 1716–1725
- Shanbhag VR, Crider MA, Gohkale R, Harpalani A, Dick RM. Ester amide and prodrugs of ibuprofen and naproxen. Synthesis, anti-inflammatory activity and gastrointestinal toxicity. J Pharm Sci 1992; 81: 149–154
- Candan F. Effect of Rhus coribum L. (Aracardiaceae) on superoxide radical scavenging and xanthine oxidase activity. J Enzyme Inhib Med Chem 2003; 18: 59–62
- Shen TY. Non steroidal anti-inflammatory agents. Burger's medicinal chemistry, ME Wolf. John Wiley and Sons, New York 1980; 1217–1219
- Winter CA. Non-steroidal anti-inflammatory drugs, S Grattini, MNG Dukes. Excepta Medica, Amsterdam 1965; 190
- Kuroda T, Suzuki F, Tamura T, Ohmori K, Hosoe H. A synthesis and potent anti-inflammatory activity of 4-hydroxy-2-(H)-oxo-1-phenyl-1,8-naphthylyridine-3-carboxamides. J Med Chem 1992; 53: 1130–1136
- Taraborewala IB, Kauffman JM. Synthesis and structure activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine alkanoic acids and 4-(-2)carboxy-phenylaminobenzene alkanoic. J Pharm Sci 1990; 79: 173–178
- Muller K. 5-lipoxygenase and 12-lipoxygenase: Attractive targets for the development of novel antipsoriatic drugs, reviews and trends. Arch Pharm 1994; 327: 3–19
- Pontiki E, Hadjipavlou-Litina D. Review in quantitative structure activity relationships on lipoxygenase inhibitors. Mini Rev Med Chem 2003; 3: 487–499
- Hadjipavlou-Litina D, Pontiki E. Quantitative structure activity relationships on lipoxygenase inhibitors. Internet Electron J Mol Des 2002; 1: 134–141
- , Biobyte Corp., 201 West 4th Str., Suite 204 Claremont CA, California 91711 USA.